Theranostics — melding precision diagnostics with targeted radiopharmaceutical therapy — has become a central focus in contemporary oncology. Middle-market investors are uniquely positioned to deploy capital into building the...more
Theranostics — melding precision diagnostics with targeted radiopharmaceutical therapy — has become a central focus in contemporary oncology. Middle-market investors are uniquely positioned to deploy capital into building the...more
Theranostics — the practice of melding precision diagnostics with targeted radiopharmaceutical therapy — has become a central focus in contemporary oncology. The therapy enables more accurate patient selection, earlier...more
The convergence of wellness, aesthetics and preventive care is creating new growth avenues for investors and operators, especially in the women’s health space. This space includes heavily cash-pay services, such as weight...more
In 2025, the U.S. radiopharmaceutical market is expected to see continued growth, driven by aging populations, advancements in theranostics, an increased demand for targeted cancer treatments and an expansion of applications...more